Jyothy Laboratories is available at the Cheapest Valuation. In fact after the Capital infusion and NCD issue, company has become debt free and will gain substantially in interest costs from next quarter onwards Keep accumulating Jyothy Lab at Current rates for a Target of Rs 300
10.07 PM Dec 5th
. Bondholders haven’t yet exercised that right, Suzlon said in its quarterly results yesterday. “There is no pressure from lenders,” Vagadia said, denying that creditors may force Suzlon to sell part of its German unit REpower Systems SE to pay down debt. “They understand the value of all the assets the company
10.05 PM Dec 5th
Dear Cindrella, I agree please. Another stock to look at seriously is Vasuvius India ; a debt free stock with promoters, MFs and other reputed entities holding the share, it would prove to be a reasonably good stock or short term. With its tie up with foreign collaboration and its product
9.01 PM Dec 5th
I feel the maximum dividend can be 400 . Consider the actual cash after retention, taxes, debt repayments,dividend tax and compliance costs. From that set apart, employee special payment, money to be retained for business plans. I think Arun kumar may akso do something similar to Piramal to reduce
8.28 PM Dec 5th
one should take mtnl valuations prior to 2k and laters. a debt free company got milked by govt and ended up as penny stock. govt is impartial so it treats all psu alike.. sbi will come to 3 digits too. ofcourse this is not a rule. but it usually happens this way only...
7.28 PM Dec 5th
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.